Effect of cheese containing gamma-aminobutyric acid-producing lactic acid bacteria on blood pressure in men

PharmaNutrition

Volumn 1, Issue 4, 2013, Pages 141-148

  Pouliot Mathieu, Kat ^a   Gardner Fortier, Catherine ^a   Lemieux, Simone ^a   St Gelais, Daniel ^a,b   Champagne, Claude P ^a,b   Vuillemard, Jean Christophe ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b FOOD RESEARCH AND DEVELOPMENT CENTRE   (Canada)

Author keywords

Antihypertensive effects; Blood pressure; Cheese; Gamma aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID;

ADULT; ARTICLE; BACTERIAL STRAIN; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY WEIGHT; CHEESE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; HEART RATE; HUMAN; HYPERTENSION; LACTOCOCCUS LACTIS; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

LACTOCOCCUS LACTIS;

EID: 84888434149     PISSN: 22134344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phanu.2013.06.003     Document Type: Article

References (55)

1. Kannel W.B., Ho K., Thom T. Changing epidemiological features of cardiac failure. British Heart Journal 1994, 72(supplement):S3-S9.
2. Wilkins K., Campbell N.R., Joffres M.R., McAlister F.A., Nichol M., Quach S., et al. Blood pressure in Canadian adults. Health Reports 2010, 21(March (1)):37-46.
3. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. New England Journal of Medicine 1997, 336:1117-1124.
4. Kumanyika S.K., Hebert P.R., Cutler J.A., Lasser V.I., Sugars C.P., Steffen-Batey, et al. Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, Phase I. Hypertension 1993, 22:502-512.
5. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. New England Journal of Medicine 2001, 344:3-10.
6. Hedayati S.S., El Sayed E.F., Reilly R.F. Non-pharmacological aspects of blood pressure management: what are the data?. Kidney International 2011, 79:1061-1070.
7. Fluegel S.M., Shultz T.D., Powers J.R., Clark S., Barbosa-Leiker C., Wright B.R., et al. Whey beverages decrease blood pressure in prehypertensive and hypertensive young men and women. International Dairy Journal 2010, 20:753-760.
8. Sanchez D., Kassan M., del Mar Contreras M., Carron R., Recio I., Montero M.J., et al. Long-term intake of a milk casein hydrolysate attenuates the development of hypertension and involves cardiovascular benefits. Pharmacological Research 2011, 63:398-404.
9. Elliott K.A.C., Hobbiger F. Gamma aminobutyric acid: circulatory and respiratory effects in different species; re-investigation of the anti-strychnine action in mice. Journal of Physiology 1959, 146:70-84.
10. Purves D., Augustine G.A., Fitzpatrick D., Hall W., LaMantia A.S., McNamara J.O., et al. Neuroscience 2008, Sinauer Associates Inc., Sunderland, MA. 4th ed.
11. Stanton H.C. Mode of action of gamma amino butyric acid on the cardiovascular system. Archives Internationales de Pharmacodynamie et de Therapie 1963, 143:195-204.
12. Clinical aspects on the use of gamma-aminobutyric acid: Inhibition in the nervous system and gamma-aminobutyric acid 1960, Research Group of Gamma-Aminobutyric Acid in Tokyo, Pergamon Press, Oxford.
13. Yoshimura M., Toyoshi T., Sano A., Izumi T., Fujii T., Konishi C., et al. Antihypertensive effect of a γ-aminobutyric acid rich tomato cultivar 'DG03-9' in spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry 2010, 58:615-619.
14. Zazzeroni R., Homan A., Thain E. Determination of γ-aminobutyric acid in food matrices by isotope dilution hydrophilic interaction chromatography coupled to mass spectrometry. Journal of Chromatographic Science 2009, 47:564-568.
15. Komatsuzaki N., Shima J., Kawamoto S., Momose H., Kimura T. Production of γ-aminobutyric acid (GABA) by Lactobacillus paracasei isolated from traditional fermented foods. Food Microbiology 2005, 22:497-504.
16. Lacroix N. Étude du potentiel aromatique technologique et fonctionnel de ferments lactiques traditionnels 2008, Université Laval, [Ph.D. Dissertation].
17. Siragusa S., De Angelis M., Di Cagno R., Rizello G.G., Coda R., Gobbetti M. Synthesis of γ-aminobutyric acid by lactic acid bacteria isolated from a variety of Italian cheeses. Applied and Environment Microbiology 2007, 73:7283-7290.
18. Nomura M., Kimoto H., Someya Y., Furukawa S., Suzuki I. Production of γ-aminobutyric acid by cheese starters during cheese ripening. Journal of Dairy Science 1998, 81:1486-1491.
19. Inoue K., Shirai T., Ochiai H., Kasao M., Hayakawa K., Kimuram M., et al. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. European Journal of Clinical Nutrition 2003, 57:490-495.
20. Lacroix N., St-Gelais D., Champagne C.P., Fortin J., Vuillemard J.C. Characterization of aromatic properties of old-style cheese starters. Journal of Dairy Science 2010, 93:3427-3441.
21. Gardner-Fortier C. Développement d'un fromage fonctionnel renfermant un composé bioactif, l'acide gamma-aminobutyrique (GABA) 2008, Université Laval, [M.Sc. Dissertation].
22. Statistics Canada Statistics of the canadian dairy industry; 2012. http://www.dairyinfo.gc.ca/pdf/publication_2012edition.pdf.
23. AOAC Official methods of analysis 1995, vol. II. Association of Official Analytical Chemists International, Arlington, [Chap. 33]. 16th ed.
24. Nielsen S.S. Food analysis 2010, Springer, West Lafayette. 4th ed.
25. Kempler G.M., McKay L.L. Improved medium for detection of citrate-fermenting Streptococcus lactis subsp. diacetylactis. Applied and Environment Microbiology 1980, 9:926-927.
26. Messaï E. Guide des chiffres et formules utilisées en pratique médicale 1995, Blackwell A, Paris.
27. Burstein M., Samaille J. Sur une nouvelle méthode de dosage du cholestérol lié aux α et aux β-lipoprotéines du sérum. Clinica Chimica Acta 1958, 3:320-327.
28. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972, 18:499-502.
29. Moorjani S., Gagné C., Lupien P.J., Brun D. Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia. Metabolism 1986, 35:311-316.
30. Labonté M.E., Cyr A., Baril-Gravel L., Royer M.M., Lamarche B. Validity and reproductibility of a web-based, self-administered food frequency questionnaire. European Journal of Clinical Nutrition 2012, 66:166-173.
31. Health Canada Canada's Food Guide; 2011. http://www.hc-sc.gc.ca/fn-an/food-guide-aliment/index-eng.php.
32. Champagne C.P., Gagnon D., St-Gelais D., Vuillemard J.C. Interactions between Lactococcus lactis and Streptococcus thermophilus strains in Cheddar cheese processing conditions. International Dairy Journal 2009, 19:669-674.
33. Daigle A., Roy D., Bélanger G., Vuillemard J.C. Production of probiotic cheese (Cheddar-like cheese) using enriched cream fermented by Bifidobacterium infantis. Journal of Dairy Science 1999, 82:1081-1091.
34. Beresford T., Williams A. The microbiology of cheese ripening. Cheese: chemistry, physics and microbiology 2004, vol. 1:287-317. Elsevier Academic Press, London. 3rd ed.
35. Lynch C.M., McSweeney P.L.H., Fox P.F., Cogan T.M., Drinan F.D. Manufacture of Cheddar cheese with and without adjunct lactobacilli under controlled microbiological conditions. International Dairy Journal 1996, 6:851-867.
36. Wallace J.M., Fox P.F. Effect of adding free amino acids to Cheddar cheese curd on proteolysis, flavour and texture development. International Dairy Journal 1997, 7:157-167.
37. Banks J.M., Yvon M., Gripon J.C., de la Fuente M.A., Brechany E.Y., Wiliams A.G., et al. Enhancement of amino acid catabolism in Cheddar cheese using α-ketoglutarate: amino acid degradation in relation to volatile compounds and other aroma character. International Dairy Journal 2001, 11:235-243.
38. Hayakawa K., Kimura M., Kasaha K., Matsumoto K., Sansawa H., Yamori Y. Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. British Journal of Nutrition 2004, 92:411-417.
39. Mesdjian E., DeFeudis F.V., Jadot G., Valli M., Brugerolle B., Bouyard P. Comparison of the cardiovascular effects of intravenously administered GABA, THIP, and isoguvacine in the anesthetized rat. Drug Development Research 1983, 3:311-318.
40. Franco I., Prieto B., Bernardo A., Prieto J.G., Carballo J. Biochemical changes throughout the ripening of a traditional Spanish goat cheese variety (Babia-Laciana). International Dairy Journal 2003, 13:221-230.
41. Ong L., Shah N.P. Influence of probiotic Lactobacillus acidophilus and L. helveticus on proteolysis, organic acid profiles, and ACE-inhibitory activity of cheddar cheeses ripened at 4, 8, and 12°C. Journal of Food and Science 2008, 73:M111-M120.
42. Saito T., Nakamura H., Kitazawa Y., Kawai Y., Isolation Itoh T. structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. Journal of Dairy Science 2000, 83:1434-1440.
43. Aihara K., Kajimoto O., Hirata H., Takahashi R., Nakamura Y. Effect of powered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of the American College of Nutrition 2005, 24:257-265.
44. FitzGerald R.J., Murray B.A., Walsh D.J. Hypotensive peptides from milk proteins. Journal of Nutrition 2004, 134:980S-988S.
45. Seppo L., Jauhiainen T., Poussa T., Korpela R.A. fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 2003, 77:326-330.
46. Minervini F., Bilancia M.T., Siragusa S., Gobbetti M., Caponio F. Fermented goats' milk produced with selected multiple starters as a potentially functional food. Food Microbiology 2009, 26:559-564.
47. O'Donovan C.M., Wilkinson M.G., Guinee T.P., Fox P.F. An investigation of the autolytic properties of three lactococcal strains during cheese ripening. International Dairy Journal 1996, 6:1149-1165.
48. Ascherio A., Rimm E.B., Giovannucci E.L., Colditz G.A., Rosner B., Willett W.C., et al. A prospective study of nutritional factors and hypertension among US men. Circulation 1992, 86:1475-1484.
49. Houston M.C., Harper K.J. Potassium, magnesium and calcium: their role in both the cause and the treatment of hypertension. Journal of Clinical Hypertension 2008, 10(7 Suppl. 2):3-11.
50. McCarron D.A. Role of adequate dietary calcium intake in the prevention and management of salt-sensitive hypertension. American Journal of Clinical Nutrition 1997, 65:712S-716S.
51. Wang L., Manson J.E., Buring J.E., Lee I.M., Sesso H.D. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 2008, 51:1073-1079.
52. Laurant P., Touyz R.M. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. Journal of Hypertension 2000, 18:1177-1191.
53. Fondation de technologie laitière du Québec. Science et technologie du lait: Transformation du lait 2002, Montréal: Presses Internationales Polytechnique. C. Vignola (Ed.).
54. Saito T., Abubakar A., Itoh T., Arai I., Aimar M.V. Development of a new type of fermented cheese whey beverage with inhibitory effects against angiotensin-converting enzyme. Tohoku Journal of Agricultural Research 1997, 48:15-23.
55. Health Canada Canadian Nutrient File; 2010. http://webprod3.hc-sc.gc.ca/cnf-fce/index-eng.jsp.